Therefore, the aim of this study was to examine the effect and mechanism of miR‐222‐3p in IDD in targeting CDKN1B, and our results will provide a new therapeutic target for the treatment of IDD. Here, CDKN1B is linked to intervertebral disk degenerative disorder.